Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Orso

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 13, 2012
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1Daniela Cimino, Cristiano De Pittà, Francesca Orso, et al.
Scientific Reports|July 2, 2024
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemiaPietro Poggio, Stefania Rocca, Federica Fusella, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 13, 2023
Stroma-derived miR-214 coordinates tumor disseminationFrancesca Orso, Federico Virga, Daniela Dettori, et al.
Breast Cancer Research : BCR|October 27, 2012
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cellsBrigitte Bisaro, Maura Montani, Georgia Konstantinidou, et al.
Cell Death Discovery|March 27, 2026
Mitochondrial IκBα fuels cancer progression through metabolic rewiring, endothelial activation, and thrombotic spreadMenga Alessio, Jessica Petiti, Roberta Basile, et al.
Cell Stem Cell|December 18, 2014
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasisBenjamin G Cuiffo, Antoine Campagne, George W Bell, et al.
Cell Death & Disease|June 30, 2022
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemiaMohammad Houshmand, Nicoletta Vitale, Francesca Orso, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Science Advances|May 8, 2021
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammationFederico Virga, Federica Cappellesso, Benoit Stijlemans, et al.
Molecular Cancer|May 16, 2024
RICTOR/mTORC2 downregulation in BRAF<sup>V600E</sup> melanoma cells promotes resistance to BRAF/MEK inhibitionLuca Ponzone, Valentina Audrito, Claudia Landi, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 13, 2012
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1Daniela Cimino, Cristiano De Pittà, Francesca Orso, et al.
Scientific Reports|July 2, 2024
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemiaPietro Poggio, Stefania Rocca, Federica Fusella, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 13, 2023
Stroma-derived miR-214 coordinates tumor disseminationFrancesca Orso, Federico Virga, Daniela Dettori, et al.
Breast Cancer Research : BCR|October 27, 2012
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cellsBrigitte Bisaro, Maura Montani, Georgia Konstantinidou, et al.
Cell Death Discovery|March 27, 2026
Mitochondrial IκBα fuels cancer progression through metabolic rewiring, endothelial activation, and thrombotic spreadMenga Alessio, Jessica Petiti, Roberta Basile, et al.
Cell Stem Cell|December 18, 2014
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasisBenjamin G Cuiffo, Antoine Campagne, George W Bell, et al.
Cell Death & Disease|June 30, 2022
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemiaMohammad Houshmand, Nicoletta Vitale, Francesca Orso, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Science Advances|May 8, 2021
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammationFederico Virga, Federica Cappellesso, Benoit Stijlemans, et al.
Molecular Cancer|May 16, 2024
RICTOR/mTORC2 downregulation in BRAF<sup>V600E</sup> melanoma cells promotes resistance to BRAF/MEK inhibitionLuca Ponzone, Valentina Audrito, Claudia Landi, et al.
Pageof 5